Integrated Investment Consultants LLC lessened its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 44.4% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,106 shares of the company’s stock after selling 5,675 shares during the quarter. Integrated Investment Consultants LLC’s holdings in Procter & Gamble were worth $1,132,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the stock. Kingstone Capital Partners Texas LLC boosted its holdings in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Norges Bank purchased a new stake in shares of Procter & Gamble in the second quarter worth about $5,099,644,000. Laurel Wealth Advisors LLC boosted its stake in Procter & Gamble by 15,971.7% during the second quarter. Laurel Wealth Advisors LLC now owns 7,012,744 shares of the company’s stock valued at $1,117,270,000 after buying an additional 6,969,110 shares during the last quarter. Vanguard Group Inc. boosted its stake in Procter & Gamble by 1.4% during the second quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company’s stock valued at $37,155,222,000 after buying an additional 3,189,111 shares during the last quarter. Finally, Invesco Ltd. increased its stake in Procter & Gamble by 21.4% in the 2nd quarter. Invesco Ltd. now owns 16,374,499 shares of the company’s stock worth $2,608,785,000 after acquiring an additional 2,880,895 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Stock Performance
Shares of Procter & Gamble stock opened at $139.60 on Wednesday. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46. The stock’s fifty day moving average is $148.52 and its two-hundred day moving average is $154.70. Procter & Gamble Company has a 52 week low of $138.14 and a 52 week high of $179.99. The company has a market capitalization of $326.21 billion, a PE ratio of 20.38, a price-to-earnings-growth ratio of 4.18 and a beta of 0.39.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Investors of record on Friday, October 24th were paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date was Friday, October 24th. Procter & Gamble’s dividend payout ratio is 61.75%.
Insiders Place Their Bets
In related news, CAO Matthew W. Janzaruk sold 725 shares of the business’s stock in a transaction that occurred on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total transaction of $108,438.25. Following the completion of the transaction, the chief accounting officer owned 979 shares in the company, valued at $146,429.03. The trade was a 42.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jennifer L. Davis sold 3,227 shares of the company’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $491,246.21. Following the transaction, the chief executive officer directly owned 61,764 shares in the company, valued at $9,402,333.72. This represents a 4.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 30,308 shares of company stock worth $4,611,852. Insiders own 0.20% of the company’s stock.
Wall Street Analysts Forecast Growth
PG has been the subject of a number of research reports. UBS Group lowered their target price on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Dbs Bank raised shares of Procter & Gamble to a “hold” rating in a research note on Friday, December 5th. BNP Paribas restated an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Barclays reduced their price objective on Procter & Gamble from $153.00 to $151.00 and set an “equal weight” rating on the stock in a research note on Monday. Finally, Berenberg Bank boosted their target price on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research report on Wednesday, September 17th. Twelve research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $171.40.
Check Out Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Top Biotech Stocks: Exploring Innovation Opportunities
- Insiders Are Selling These 3 Stocks—Here’s Why
- Canada Bond Market Holiday: How to Invest and Trade
- Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers
- The 3 Best Retail Stocks to Shop for in August
- 10X Gains? These 3 Robotics Stocks Could Explode by 2035
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
